Aviva’s Chemours CC Stock Holding History

Aviva’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72,716	Closed	-$1.79M	–	1004
2022 Q3	$1.79M	Buy	72,716 +42,433	+140%	+$1.4M	0.01%	722
2022 Q2	$970K	Buy	+30,283	New	+$1.11M	0.01%	966
2015 Q4	–	Sell	-91,452	Closed	-$592K	–	831
2015 Q3	$592K	Buy	+91,452	New	+$957K	﹤0.01%	772

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aviva's CC Position: Q4 2022 in Review

Aviva sold out of Chemours (CC) in Q4 2022, closing a stake of 72,716 shares — an estimated $1.79M sold.

Aviva first reported a position in CC in Q3 2015 and held it in 3 quarters. The position peaked at $1.79M in Q3 2022. 473 funds tracked by Wall St. Rank hold CC as of Q4 2022.

Aviva reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
Aviva sold 72,716 Chemours shares in Q4 2022, an estimated $1.79M.
Aviva first reported a position in Chemours in Q3 2015 and held it in 3 quarters.
Aviva's Chemours position peaked at $1.79M in Q3 2022.
473 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.